APPLICATION
ANDA211082
TYPE
ANDA
ORIGINAL APPROVAL
2019-07-05
LATEST ACTION
2020-01-29
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
RANOLAZINEPrescription
RANOLAZINE 1GM · TABLET, EXTENDED RELEASE · ORAL
RANOLAZINEPrescription
RANOLAZINE 500MG · TABLET, EXTENDED RELEASE · ORAL
Approval history
2020-01-29Labeling · Supplement 2 · standardAP
2020-01-29Labeling · Supplement 1 · standardAP
2019-07-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.